Want to join the conversation?
$D forecast 2Q16 operating earnings in the range of $0.65-$0.75 per share, compared to 2Q15 operating earnings of $0.73 per share. Positive drivers include an increase in revenues from growth projects, lower capacity expenses and higher anticipated investment tax credits from solar facilities, the company said.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?